Furuta T et al. |
Effect of dosing schemes of amoxicillin on eradication rates of Helicobacter pylori with amoxicillin-based triple therapy. |
2014 |
J Clin Pharmacol |
pmid:24122836
|
Ratzinger F et al. |
Azithromycin suppresses CD4(+) T-cell activation by direct modulation of mTOR activity. |
2014 |
Sci Rep |
pmid:25500904
|
Trotti LM et al. |
Improvement in daytime sleepiness with clarithromycin in patients with GABA-related hypersomnia: Clinical experience. |
2014 |
J. Psychopharmacol. (Oxford) |
pmid:24306133
|
Nie W et al. |
[The analysis of species identification and susceptibility testing of Mycobacterium abscessus]. |
2014 |
Zhonghua Jie He He Hu Xi Za Zhi |
pmid:25262693
|
Campanale M et al. |
Nickel free-diet enhances the Helicobacter pylori eradication rate: a pilot study. |
2014 |
Dig. Dis. Sci. |
pmid:24595654
|
Svanström H et al. |
Use of clarithromycin and roxithromycin and risk of cardiac death: cohort study. |
2014 |
BMJ |
pmid:25139799
|
Giamarellos-Bourboulis EJ et al. |
Effect of clarithromycin in patients with suspected Gram-negative sepsis: results of a randomized controlled trial. |
2014 |
J. Antimicrob. Chemother. |
pmid:24292991
|
Jung YS et al. |
[Trends in the eradication rates of Helicobacter pylori infection in Daegu and Gyeongsangbuk-do, Korea: multicenter study over 13 years]. |
2014 |
Korean J Gastroenterol |
pmid:24561694
|
Vanderpas J et al. |
Follow-up of Helicobacter pylori infection in children over two decades (1988-2007): persistence, relapse and acquisition rates. |
2014 |
Epidemiol. Infect. |
pmid:23809783
|
Oğuz M and Mihçiokur H |
Environmental risk assessment of selected pharmaceuticals in Turkey. |
2014 |
Environ. Toxicol. Pharmacol. |
pmid:24929476
|
de Masson A et al. |
Cavitary pulmonary disease in a patient treated with natalizumab. |
2014 |
Presse Med |
pmid:24742610
|
Furuta T et al. |
Sitafloxacin-based third-line rescue regimens for Helicobacter pylori infection in Japan. |
2014 |
J. Gastroenterol. Hepatol. |
pmid:24224808
|
Noguchi S et al. |
Polymorphic transformation of antibiotic clarithromycin under acidic condition. |
2014 |
J Pharm Sci |
pmid:24375227
|
Komiya K et al. |
Long-term, low-dose erythromycin monotherapy for Mycobacterium avium complex lung disease: a propensity score analysis. |
2014 |
Int. J. Antimicrob. Agents |
pmid:24948577
|
de Miguel-Martinez I et al. |
[Bacteriemia due to Mycobacterium canariasense in an oncohematological patient with a long-term central device]. |
2014 |
Enferm. Infecc. Microbiol. Clin. |
pmid:25262854
|
Gui J et al. |
[Subspecies identification for Mycobacterium abscessus group]. |
2014 |
Zhonghua Jie He He Hu Xi Za Zhi |
pmid:25262692
|
Ghrew MH et al. |
Successful renal transplant in patient with controlled pulmonary non-tuberculous mycobacterium infection. |
2014 |
Libyan J Med |
pmid:25249307
|
Higgins JW et al. |
Clinical CYP3A inhibitor alternatives to ketoconazole, clarithromycin and itraconazole, are not transported into the liver by hepatic organic anion transporting polypeptides and organic cation transporter 1. |
2014 |
Drug Metab. Dispos. |
pmid:25106415
|
Nilsson MF and Webster WS |
Effects of macrolide antibiotics on rat embryonic heart function in vitro. |
2014 |
Birth Defects Res. B Dev. Reprod. Toxicol. |
pmid:24753334
|
Peng YC et al. |
Clarithromycin modulates Helicobacter pylori-induced activation of nuclear factor-κB through classical and alternative pathways in gastric epithelial cells. |
2014 |
Clin. Exp. Med. |
pmid:23129507
|
Heo J et al. |
A randomised clinical trial of 10-day concomitant therapy and standard triple therapy for Helicobacter pylori eradication. |
2014 |
Dig Liver Dis |
pmid:25132282
|
Lebedeva MV et al. |
Clarithromycin as a chiral selector for enantioseparation of basic compounds in nonaqueous capillary electrophoresis. |
2014 |
Electrophoresis |
pmid:25100556
|
Katayama M et al. |
Preliminary study of interaction of clarithromycin with tacrolimus in cats. |
2014 |
J. Vet. Med. Sci. |
pmid:25099737
|
Park CS et al. |
Pretreatment antimicrobial susceptibility-guided vs. clarithromycin-based triple therapy for Helicobacter pylori eradication in a region with high rates of multiple drug resistance. |
2014 |
Am. J. Gastroenterol. |
pmid:25091062
|
Vafaeimanesh J et al. |
Expression comparison of azithromycin and clarithromycin in triple-therapy regimens for eradication of Helicobacter pylori in hemodialysis patients. |
2014 |
Saudi J Kidney Dis Transpl |
pmid:24434382
|
Bonferoni MC et al. |
Ionic polymeric micelles based on chitosan and fatty acids and intended for wound healing. Comparison of linoleic and oleic acid. |
2014 |
Eur J Pharm Biopharm |
pmid:24384070
|
Liu CP et al. |
NO-releasing xanthine KMUP-1 bonded by simvastatin attenuates bleomycin-induced lung inflammation and delayed fibrosis. |
2014 |
Pulm Pharmacol Ther |
pmid:23518214
|
Philips RC et al. |
Mycobacterium fortuitum infection arising in a new tattoo. |
2014 |
Dermatol. Online J. |
pmid:24945647
|
Jarand J and Field SK |
Embrace simplicity when treating lady windermere. |
2014 |
Chest |
pmid:25091749
|
Luo Q et al. |
[Clinical effect of clarithromycin therapy in patients with chronic rhinosinusitis]. |
2014 |
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi |
pmid:24742507
|
Trotti LM et al. |
Further experience using clarithromycin in patients with Kleine-Levin syndrome. |
2014 |
J Clin Sleep Med |
pmid:24733995
|
Khalili N |
Sunny hypomania associated with clarithromycin: a case report. |
2014 |
J Clin Psychopharmacol |
pmid:24717249
|
Onyekwere CA et al. |
Rabeprazole, clarithromycin, and amoxicillin Helicobacter pylori eradication therapy: report of an efficacy study. |
2014 |
World J. Gastroenterol. |
pmid:24707145
|
Wu JY et al. |
Detection of genotypic clarithromycin-resistant Helicobacter pylori by string tests. |
2014 |
World J. Gastroenterol. |
pmid:24695835
|
Ali Habib HS et al. |
Effect of sequential versus standard Helicobacter pylori eradication therapy on the associated iron deficiency anemia in children. |
2013 Sep-Oct |
Indian J Pharmacol |
pmid:24130381
|
Mégraud F |
Current recommendations for Helicobacter pylori therapies in a world of evolving resistance. |
2013 Nov-Dec |
Gut Microbes |
pmid:23929066
|
Suzaki I et al. |
Enhancement of thioredoxin production from nasal epithelial cells by the macrolide antibiotic, clarithromycin in vitro. |
2013 May-Jun |
In Vivo |
pmid:23606690
|
Dajani AI et al. |
Do probiotics improve eradication response to Helicobacter pylori on standard triple or sequential therapy? |
2013 May-Jun |
Saudi J Gastroenterol |
pmid:23680708
|
Petitto J et al. |
Successful clarithromycin desensitization in a macrolide-sensitive pediatric patient. |
2013 May-Jun |
J Allergy Clin Immunol Pract |
pmid:24565493
|
Cottle LE et al. |
A multinational outbreak of histoplasmosis following a biology field trip in the Ugandan rainforest. |
2013 Mar-Apr |
J Travel Med |
pmid:23464714
|
Molina-Infante J and Gisbert JP |
[Update on the efficacy of triple therapy for Helicobacter pylori infection and clarithromycin resistance rates in Spain (2007-2012)]. |
2013 Jun-Jul |
Gastroenterol Hepatol |
pmid:23623461
|
Razafimahefa SH et al. |
[Helicobacter pylori: what eradication regimen in a tropical area after the failure of two separate lines of eradication including metronidazole and clarithromycin?]. |
2013 Jan-Mar |
Med Sante Trop |
pmid:23360589
|
Mandras N et al. |
Antibacterial efficacy and drug-induced tooth discolouration of antibiotic combinations for endodontic regenerative procedures. |
2013 Apr-Jun |
Int J Immunopathol Pharmacol |
pmid:23755774
|
Nasa M et al. |
Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized study. |
2013 |
Indian J Gastroenterol |
pmid:24158898
|
Kim SY et al. |
Comparative study of Helicobacter pylori eradication rates with 5-day quadruple "concomitant" therapy and 7-day standard triple therapy. |
2013 |
J. Clin. Gastroenterol. |
pmid:22647826
|
Duman DG et al. |
Saccharomyces boulardii ameliorates clarithromycin- and methotrexate-induced intestinal and hepatic injury in rats. |
2013 |
Br. J. Nutr. |
pmid:23279717
|
Pandey SK et al. |
Antimalarial interaction of quinine and quinidine with clarithromycin. |
2013 |
Parasitology |
pmid:23137860
|
Mueck W et al. |
Co-administration of rivaroxaban with drugs that share its elimination pathways: pharmacokinetic effects in healthy subjects. |
2013 |
Br J Clin Pharmacol |
pmid:23305158
|
Karmakar S et al. |
Hypokalemia: a potent risk for QTc prolongation in clarithromycin treated rats. |
2013 |
Eur. J. Pharmacol. |
pmid:23567068
|
Abenavoli L et al. |
Association between non-alcoholic fatty liver disease, insulin resistance and Helicobacter pylori. |
2013 |
Med. Hypotheses |
pmid:24011768
|